IOVA Other | IOVANCE BIOTHERAPEUTICS, INC.

IOVANCE BIOTHERAPEUTICS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2026-02-24: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ.
2025-02-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ.
2024-02-28: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ.
2023-02-28: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ.

Filed	Form	Item	As filed
2026-02-24	10-K	Stock registered under Section 12(b)	Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ
2025-02-27	10-K	Stock registered under Section 12(b)	Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ
2024-02-28	10-K	Stock registered under Section 12(b)	Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ
2023-02-28	10-K	Stock registered under Section 12(b)	Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ
2022-02-24	10-K	Stock registered under Section 12(b)	Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ
2022-02-24	10-K	Well-known seasoned issuer	No
2021-11-04	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.000041666 per value · IOVA · NASDAQ
2021-08-05	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.000041666 per value · IOVA · NASDAQ
2021-05-06	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.000041666 per value · IOVA · NASDAQ
2021-02-25	10-K	Stock registered under Section 12(b)	Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ
2021-02-25	10-K	Well-known seasoned issuer	No
2020-11-05	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.000041666 per value · IOVA · NASDAQ
2020-08-06	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.000041666 per value · IOVA · NASDAQ
2020-05-05	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.000041666 per share · IOVA · NASDAQ
2020-02-25	10-K	Stock registered under Section 12(b)	Common Stock, $ 0.000041666 Par Value per Share · IOVA · NASDAQ
2020-02-25	10-K	Well-known seasoned issuer	No
2019-11-04	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.000041666 per value · IOVA · NASDAQ
2019-08-01	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.000041666 per value · IOVA · NASDAQ
2019-02-28	10-K	Well-known seasoned issuer	No
2018-03-12	10-K	Well-known seasoned issuer	No
2017-03-09	10-K	Well-known seasoned issuer	No
2016-03-11	10-K	Well-known seasoned issuer	No
2015-03-16	10-K	Well-known seasoned issuer	No
2014-11-13	10-Q	Well-known seasoned issuer	No
2014-08-08	10-Q	Well-known seasoned issuer	No
2014-05-14	10-Q	Well-known seasoned issuer	No
2014-03-28	10-K	Well-known seasoned issuer	No
2013-11-14	10-Q	Well-known seasoned issuer	No
2013-10-23	10-Q	Current in its reporting	No
2013-10-23	10-Q	Well-known seasoned issuer	No
2013-10-23	10-Q	Well-known seasoned issuer	No
2013-09-23	10-K	Well-known seasoned issuer	No
2013-01-25	10-Q	Well-known seasoned issuer	No
2012-09-10	10-Q/A	Well-known seasoned issuer	No
2012-05-15	10-Q	Well-known seasoned issuer	No
2012-03-30	10-K	Well-known seasoned issuer	No
2011-11-21	10-Q	Well-known seasoned issuer	No
2011-09-01	10-Q/A	Well-known seasoned issuer	No

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Adaptive Biotechnologies Corp (ADPT)	United States	$4.719B	-53.43
CRISPR Therapeutics AG (CRSP)		$5.390B	-11.68
Relay Therapeutics, Inc. (RLAY)	United States	$3.884B	-14.30
Scholar Rock Holding Corp (SRRK)	United States	$5.920B	-16.37
CG Oncology, Inc. (CGON)	United States	$6.095B	-27.95
Tarsus Pharmaceuticals, Inc. (TARS)	United States	$3.329B	-58.60
Denali Therapeutics Inc. (DNLI)	United States	$3.274B	-8.04
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78
Beam Therapeutics Inc. (BEAM)	United States	$2.549B	-41.51
Greenland Mines Ltd (GRML)	United States	$2.362B